Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GenBio AI
Palo Alto, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
GenBio AI has released six multiscale foundation models for DNA, RNA, protein, cell, and evolutionary biology, enabling researchers to rapidly simulate millions of compounds and biological scenarios for drug design, precision medicine, and disease modeling. Results have been peer-reviewed and presented at major AI conferences (NeurIPS).
- Therapeutic areas
- OncologyOtherInfectious Diseases
- Modalities
- Small moleculeRNA therapyProteinCell modeling
- Industry
- Drug Discovery Services
02
Partnerships
Carnegie Mellon University (CMU)Stanford UniversityWeizmann Institute of ScienceMBZUAIHelmholtz Munich
Beyond the preview
Go deeper on GenBio AI.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GenBio AI.